ARCHIVES

Conversation With The Cancer Letter: PanCAN CEO Denies Bill Would Undermine NCI’s Role in Directing and Funding Research

This article is from The Cancer Letter archive.

Vol. 38 No. 31 | August 3, 2012

Download PDF Visit The Full Archive

Related Articles

Nexavar Phase III Trial Fails To Meet Primary Endpoint

June 29, 2012

Also Bristol-Myers Squibb Under Federal Investigation Over Plavix Deal.

July 28, 2006

Senate Votes To Invalidate Task Force Guideline

December 4, 2009

NRC Group Splits Over chemical Dose Testing For Carcinogenicity

March 12, 1993

GAO Offers Two Suggestions For Plant Screening

April 4, 1980

St. Vincent Of NYC Joins Funded CCOPS Spurr To Be Professor Emeritus; UCOG, Still Unfunded, Still Active

May 1, 1987